Drugs / VM902A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02847702 | Aug → Nov 2016 | osteoarthritis, knee | Purdue Pharma LP | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VM902A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02847702 ↗ |
| Route | Oral | “Taken orally with food twice daily” NCT02847702 ↗ |